|
Surfactant
Replacement Therapy
In the last 10 years several
pharmaceutical companies, including Chiesi Pharmaceuticals
have started producing surfactants that can be given to babies
at risk of developing RDS,
as either a preventative treatment or to treat babies that
already have signs of RDS.
Surfactant is administered
to babies directly to the lungs through a endotracheal tube
(breathing tube) that is placed in the baby’s windpipe
(also called trachea).
The amount and the number
of doses required vary between surfactants and also between
babies. Most babies respond relatively quickly to treatment
however others may take a little longer , and a few have little
or no response. Some babies who responded initially may relapse
and need further surfactant treatment. Babies that respond
well require less support from ventilators and lower additional
oxygen support.
For
further information see About
Curosurf
|
